Enterprise record

Estrella Immunopharma, Inc. logo

Estrella Immunopharma, Inc.

Public governance Claims and source records for this enterprise.

Alpha ID: alpha:company:a73ed67a-45ed-4a5a-a5e9-0c2e4194c024Version: public-1As of: unavailable

6 published Claims3 sources

Key Claims

Board and committees

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of Sep 29, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Alpha canonical company public projection

    canonical identity · Source published: Date unavailable · Retrieved: Sep 29, 2026

    Supports 3 claims
    • Legal Name: Estrella Immunopharma, Inc. · Claim reviewed: Sep 29, 2026
    • Entity Status: Public listing published · Claim reviewed: Sep 29, 2026
    • Published Fact: US · Claim reviewed: Sep 29, 2026
  2. Estrella Immunopharma, Inc. DEF 14A 2023-06-16

    sec proxy · Source published: Jun 16, 2023 · Retrieved: Apr 29, 2026

    Supports 2 claims
    • Leadership Role: Jason Long: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Tao Jiang: Director · Claim reviewed: Sep 29, 2026
  3. ESLA 10-K executive officers

    sec filing · Source published: Mar 18, 2026 · Retrieved: May 16, 2026

    Supports 1 claim
    • Leadership Role: Not provided in excerpt: Chief Financial Officer · Claim reviewed: Sep 29, 2026